Ascendis Pharma A/S
ASND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612042
In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Ascendis Pharma A/S as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 274
- −26 vs. Q4 2025
- Shares held
- 62.7M
- −2.01M (−3.1%) vs. Q4 2025
- Total value
- $14.3B
- +$541.7M (+3.9%) vs. Q4 2025
- New holders
- 34
- 109 more added
- Sold out
- 60
- 106 more reduced
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASND on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 313 | $17.8B |
| Q1 2026 | 274 | $14.3B |
| Q4 2025 | 303 | $13.8B |
| Q3 2025 | 281 | $12.7B |
| Q2 2025 | 248 | $10.9B |
| Q1 2025 | 245 | $10.1B |
| Q4 2024 | 215 | $8.78B |
| Q3 2024 | 220 | $9.31B |
| Q2 2024 | 203 | $8.28B |
| Q1 2024 | 189 | $9.19B |
| Q4 2023 | 185 | $7.59B |
| Q3 2023 | 160 | $5.64B |
| Q2 2023 | 158 | $5.45B |
| Q1 2023 | 164 | $6.54B |
| Q4 2022 | 187 | $8.05B |
| Q3 2022 | 183 | $6.89B |
| Q2 2022 | 168 | $5.88B |
| Q1 2022 | 177 | $7.27B |
| Q4 2021 | 172 | $7.85B |
| Q3 2021 | 166 | $9.24B |
| Q2 2021 | 171 | $7.24B |
| Q1 2021 | 177 | $6.83B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Ascendis Pharma A/S; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Turn Management, LLC | 76,300 | $17.5M | 1.95% | −55,508−42.1% | Reduced |
| National Bank of Canada | 80,017 | $18.3M | 0.02% | +80,017 | New |
| Loomis Sayles & Co L P | 80,405 | $18.4M | 0.02% | −31,835−28.4% | Reduced |
| Eagle Health Investments LP | 86,650 | $19.8M | 4.16% | +86,650 | New |
| State Street Corp | 87,334 | $20.0M | 0.00% | +19,385+28.5% | Added |
| Arrowstreet Capital, Limited Partnership | 91,470 | $20.9M | 0.01% | +91,470 | New |
| Cormorant Asset Management, LP | 95,000 | $21.7M | 1.10% | −5,000−5.0% | Reduced |
| Affinity Asset Advisors, LLC | 95,000 | $21.7M | 1.27% | +65,000+216.7% | Added |
| Resolute Capital Asset Partners LLC | 98,627 | $22.6M | 11.87% | +10,000+11.3% | Added |
| Troluce Capital Advisors LLC | 99,600 | $22.8M | 2.41% | +99,600 | New |
| Q Global Advisors, LLC | 100,000 | $22.9M | 21.99% | −90,000−47.4% | Reduced |
| Perpetual Ltd | 100,638 | $23.0M | 0.35% | +100,638 | New |
| Woodline Partners LP | 102,469 | $23.4M | 0.09% | +80.0% | Added |
| Voloridge Investment Management, LLC | 114,275 | $26.1M | 0.10% | −101,898−47.1% | Reduced |
| Integral Health Asset Management, LLC | 115,000 | $26.3M | 1.39% | +25,000+27.8% | Added |
| Renaissance Technologies LLC | 117,332 | $26.8M | 0.04% | +117,332 | New |
| SG Americas Securities, LLC | 120,790 | $27.6M | 0.03% | +109,577+977.2% | Added |
| Chevy Chase Trust Holdings, Inc. | 123,467 | $28.2M | 0.08% | +66,772+117.8% | Added |
| Silverarc Capital Management, LLC | 124,658 | $28.5M | 3.36% | +75,430+153.2% | Added |
| Driehaus Capital Management LLC | 127,562 | $29.2M | 0.21% | −28,710−18.4% | Reduced |
| Oddo BHF Asset Management SAS | 128,657 | $29.4M | 1.16% | −1,284−1.0% | Reduced |
| Catalio Capital Management, LP | 129,111 | $29.5M | 6.17% | +9,846+8.3% | Added |
| Braun Stacey Associates Inc | 130,992 | $30.0M | 1.00% | +11,897+10.0% | Added |
| Frazier Life Sciences Management, L.P. | 133,333 | $30.5M | 0.78% | 00.0% | Unchanged |
| Deutsche Bank AG | 135,187 | $30.9M | 0.01% | −161,631−54.5% | Reduced |
| Lord, Abbett & Co. LLC | 145,317 | $33.2M | 0.11% | +25,120+20.9% | Added |
| Rice Hall James & Associates, LLC | 148,386 | $33.9M | 1.89% | +3,340+2.3% | Added |
| PFM Health Sciences, LP | 152,034 | $34.8M | 3.66% | −25,651−14.4% | Reduced |
| Wells Fargo & Company | 154,199 | $35.3M | 0.01% | +120,419+356.5% | Added |
| New York State Common Retirement Fund | 171,112 | $39.1M | 0.05% | −11,122−6.1% | Reduced |
| OrbiMed Advisors LLC | 181,977 | $41.6M | 0.95% | +10,000+5.8% | Added |
| Allspring Global Investments Holdings, LLC | 184,224 | $42.0M | 0.07% | −3,418−1.8% | Reduced |
| Millennium Management LLC | 189,027 | $43.2M | 0.03% | −73,302−27.9% | Reduced |
| Rock Springs Capital Management LP | 194,000 | $44.4M | 2.62% | −9,500−4.7% | Reduced |
| Bank of America Corp | 198,505 | $45.4M | 0.00% | +36,002+22.2% | Added |
| UBS Group AG | 207,339 | $47.4M | 0.01% | −100,851−32.7% | Reduced |
| ARS Investment Partners, LLC | 209,456 | $47.9M | 2.49% | +34,845+20.0% | Added |
| Standard Life Aberdeen plc | 210,154 | $48.1M | 0.08% | −11,523−5.2% | Reduced |
| TD Asset Management Inc | 217,992 | $49.9M | 0.04% | −16,020−6.8% | Reduced |
| Two Sigma Investments, LP | 220,341 | $50.4M | 0.04% | −27,551−11.1% | Reduced |
| Bank of New York Mellon Corp | 228,675 | $52.3M | 0.01% | +34,070+17.5% | Added |
| Candriam Luxembourg S.C.A. | 230,278 | $52.7M | 0.27% | +43,338+23.2% | Added |
| Pictet Asset Management Holding SA | 251,833 | $56.9M | 0.06% | +178,415+243.0% | Added |
| Tri Locum Partners LP | 255,332 | $58.4M | 8.20% | −9,683−3.7% | Reduced |
| Alliancebernstein L.P. | 278,203 | $59.3M | 0.02% | −10,389−3.6% | Reduced |
| Fred Alger Management, LLC | 304,896 | $69.7M | 0.31% | −47,213−13.4% | Reduced |
| BNP Paribas Arbitrage, SA | 309,173 | $70.7M | 0.05% | +2,087+0.7% | Added |
| SEI Investments Co | 351,146 | $80.3M | 0.07% | +69,673+24.8% | Added |
| Invesco Ltd. | 362,109 | $82.8M | 0.01% | −223,985−38.2% | Reduced |
| Spyglass Capital Management LLC | 367,972 | $84.2M | 5.96% | −47,577−11.4% | Reduced |
| Vestal Point Capital, LP | 375,000 | $85.8M | 2.40% | +200,000+114.3% | Added |
| FIL Ltd | 447,421 | $102.3M | 0.08% | −31,220−6.5% | Reduced |
| Ameriprise Financial Inc | 476,466 | $109.0M | 0.03% | −74,011−13.4% | Reduced |
| JPMorgan Chase & Co | 539,434 | $117.8M | 0.01% | +32,194+6.3% | Added |
| Nomura Asset Management International Inc. | 556,427 | $127.3M | 0.22% | +59,590+12.0% | Added |
| Goldman Sachs Group Inc | 566,192 | $129.5M | 0.02% | −30,511−5.1% | Reduced |
| Morgan Stanley | 606,348 | $138.7M | 0.01% | −11,620−1.9% | Reduced |
| Polar Capital Holdings Plc | 651,712 | $149.1M | 0.65% | +281,239+75.9% | Added |
| BlackRock, Inc. | 661,054 | $151.2M | 0.00% | +32,854+5.2% | Added |
| Principal Financial Group Inc | 896,397 | $205.0M | 0.11% | −130,010−12.7% | Reduced |
| Capital World Investors | 900,517 | $206.0M | 0.03% | +900,517 | New |
| American Century Companies Inc | 1,397,119 | $319.6M | 0.16% | −46,022−3.2% | Reduced |
| Price T Rowe Associates Inc | 1,530,345 | $350.0M | 0.04% | −39,915−2.5% | Reduced |
| Perceptive Advisors LLC | 1,531,421 | $350.3M | 6.92% | +450,000+41.6% | Added |
| Wellington Management Group LLP | 1,757,633 | $402.0M | 0.08% | −5,088−0.3% | Reduced |
| Massachusetts Financial Services Co | 1,860,669 | $425.6M | 0.14% | −25,724−1.4% | Reduced |
| Capital International Investors | 1,958,843 | $448.0M | 0.11% | −1,105,100−36.1% | Reduced |
| Franklin Resources Inc | 2,051,948 | $469.3M | 0.11% | +141,869+7.4% | Added |
| Artisan Partners Limited Partnership | 3,230,188 | $738.8M | 1.21% | +4,303+0.1% | Added |
| FMR LLC | 3,876,601 | $886.7M | 0.05% | −276,710−6.7% | Reduced |
| Westfield Capital Management Co LP | 4,813,440 | $1.10B | 4.62% | −372,256−7.2% | Reduced |
| Avoro Capital Advisors LLC | 5,062,500 | $1.16B | 11.41% | −48,611−1.0% | Reduced |
| T. Rowe Price Investment Management, Inc. | 6,162,042 | $1.41B | 0.97% | +4,494,417+269.5% | Added |
| Ra Capital Management, L.P. | 10,281,496 | $2.35B | 24.92% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −4,061,641−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −519,516−100.0% | Sold out |
| Siren, L.L.C. | 0 | $0 | 0.00% | −235,862−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| IMC-Chicago, LLC | 0 | $0 | 0.00% | −113,682−100.0% | Sold out |
| 1832 Asset Management L.P. | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −82,888−100.0% | Sold out |
| Beck Bode, LLC | 0 | $0 | 0.00% | −81,087−100.0% | Sold out |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0 | $0 | 0.00% | −72,106−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −48,241−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −47,400−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −39,135−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −38,990−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −30,055−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −27,600−100.0% | Sold out |
| Brown Advisory Inc | 0 | $0 | 0.00% | −24,544−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −24,079−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −22,734−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −21,225−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −16,371−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −16,338−100.0% | Sold out |
| Zweig-DiMenna Associates LLC | 0 | $0 | 0.00% | −15,500−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −15,478−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −14,842−100.0% | Sold out |
| Main Management ETF Advisors, LLC | 0 | $0 | 0.00% | −10,962−100.0% | Sold out |